ICU 醫療公司
US ˙ NasdaqGS ˙ US44930G1076

SecurityICUI / ICU Medical, Inc.
InstitutionAperio Group, LLC
Latest Disclosed Ownership27,854 shares
Latest Disclosed Value $ 5,975,000
Aperio Group, LLC reports 32.36% increase in ownership of ICUI / ICU Medical, Inc.

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 27,854 shares of ICU Medical, Inc. (US:ICUI) valued at $5,974,404 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 21,044 shares of ICU Medical, Inc.. This represents a change in shares of 32.36% during the quarter. The current value of the position is $3,805,135 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F ICU MED COM 44930G107 27,854 6,810 32.36 5,975 55.36 0.0177
2020-11-06 2020-09-30 13F ICU MED COM 44930G107 21,044 -1,105 -4.99 3,846 -5.80 0.0130
2020-08-13 2020-06-30 13F ICU MED COM 44930G107 22,149 -6,654 -23.10 4,083 -29.74 0.0151
2020-05-05 2020-03-31 13F ICU MED COM 44930G107 28,803 -2,110 -6.83 5,811 0.45 0.0257
2020-02-13 2019-12-31 13F ICU MED COM 44930G107 30,913 14,585 89.33 5,785 121.99 0.0208
2019-11-06 2019-09-30 13F ICU MED COM 44930G107 16,328 7,997 95.99 2,606 24.21 0.0103
2019-07-30 2019-06-30 13F ICU MED COM 44930G107 8,331 -443 -5.05 2,098 -0.10 0.0086
2019-05-13 2019-03-31 13F ICU MED COM 44930G107 8,774 120 1.39 2,100 5.69 0.0091
2019-05-06 2018-12-31 13F/A-1 ICU MED COM 44930G107 8,654 -643 -6.92 1,987 -24.42 0.0100
2019-02-14 2018-12-31 13F ICU MED COM 44930G107 8,544 -753 1,962
2019-05-06 2018-09-30 13F/A-1 ICU MED COM 44930G107 9,297 11 0.12 2,629 -3.59 0.0116
2018-10-17 2018-09-30 13F ICU MED INC COM COMMON 44930G107 9,297 11 2,629
2019-05-06 2018-06-30 13F/A-1 ICU MED COM 44930G107 9,286 587 6.75 2,727 24.18 0.0130
2018-07-30 2018-06-30 13F ICU MED INC COM COMMON 44930G107 9,286 587 2,727
2019-05-01 2018-03-31 13F/A-1 ICU MED COM 44930G107 8,699 597 7.37 2,196 25.49 0.0109
2018-05-08 2018-03-31 13F ICU MED INC COM COMMON 44930G107 8,699 597 2,196
2019-05-01 2017-12-31 13F/A-1 ICU MED COM 44930G107 8,102 326 4.19 1,750 21.11 0.0090
2018-02-02 2017-12-31 13F ICU MED INC COM COMMON 44930G107 8,102 326 1,750
2019-05-01 2017-09-30 13F/A-1 ICU MED COM 44930G107 7,776 255 3.39 1,445 11.41 0.0082
2017-10-25 2017-09-30 13F ICU MED INC COM COMMON 44930G107 7,776 255 1,445
2019-04-22 2017-06-30 13F/A-1 ICU MED COM 44930G107 7,521 668 9.75 1,297 24.00 0.0079
2017-07-18 2017-06-30 13F ICU MED INC COM COMMON 44930G107 7,521 668 1,297
2019-04-22 2017-03-31 13F/A-1 ICU MED COM 44930G107 6,853 12 0.18 1,046 3.77 0.0072
2017-05-05 2017-03-31 13F ICU MED INC COM COMMON 44930G107 6,853 12 1,046
2019-04-22 2016-12-31 13F/A-1 ICU MED COM 44930G107 6,841 208 3.14 1,008 20.29 0.0077
2017-02-14 2016-12-31 13F ICU MED INC COM COMMON 44930G107 6,841 208 1,008
2019-04-12 2016-09-30 13F/A-1 ICU MED COM 44930G107 6,633 320 5.07 838 17.70 0.0061
2016-11-01 2016-09-30 13F ICU MED INC COM COMMON 44930G107 6,633 320 838
2019-04-12 2016-06-30 13F/A-1 ICU MED COM 44930G107 6,313 79 1.27 712 9.71 0.0056
2016-08-12 2016-06-30 13F ICU MED INC COM COMMON 44930G107 6,313 79 712
2019-04-12 2016-03-31 13F/A-1 ICU MED COM 44930G107 6,234 -183 -2.85 649 -10.36 0.0056
2016-04-28 2016-03-31 13F ICU MED INC COM COMMON 44930G107 6,234 -183 649
2016-01-21 2015-12-31 13F ICU MED INC COM COMMON 44930G107 6,417 851 15.29 724 18.88 0.0066
2015-10-19 2015-09-30 13F ICU MED INC COM COMMON 44930G107 5,566 -262 -4.50 609 9.14 0.0062
2015-07-29 2015-06-30 13F ICU MED INC COM COMMON 44930G107 5,828 905 18.38 558 21.57 0.0058
2015-04-29 2015-03-31 13F ICU MED INC COM COMMON 44930G107 4,923 4,923 0.00 459 0.0051
2015-01-30 2014-12-31 13F ICU MED INC COM COMMON 44930G107 0 -3,168 -100.00 0 -100.00
2014-10-21 2014-09-30 13F ICU MED INC COM COMMON 44930G107 3,168 203
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.